Imricor Medical Systems (ASX:IMR) secured the first order for equipment and consumables comprising its real-time cardiac ablation imaging technology in Qatar, according to a Monday filing with the Australian bourse.
The sale was made following regulatory approvals for the cardiac imaging system in both Qatar and Saudi Arabia earlier in the year, the filing said.
The company's shares surged past 9% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.